Stockreport

4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF EMERYVILLE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advanci [Read more]